In hematological malignancies, increased levels of MCL-1 have been described in multiple myeloma (MM) [37], DLBCL [38], AML, chronic myeloid leukemia (CML) and mantle cell lymphoma (MCL). Here, MCL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.